0001752724-20-178002.txt : 20200828 0001752724-20-178002.hdr.sgml : 20200828 20200828113932 ACCESSION NUMBER: 0001752724-20-178002 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200828 PERIOD START: 20200930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LOOMIS SAYLES FUNDS II CENTRAL INDEX KEY: 0000872649 IRS NUMBER: 043113285 STATE OF INCORPORATION: MA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-06241 FILM NUMBER: 201146245 BUSINESS ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-449-2810 MAIL ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 FORMER COMPANY: FORMER CONFORMED NAME: LOOMIS SAYLES FUNDS I DATE OF NAME CHANGE: 20031119 FORMER COMPANY: FORMER CONFORMED NAME: LOOMIS SAYLES FUNDS DATE OF NAME CHANGE: 20031015 FORMER COMPANY: FORMER CONFORMED NAME: LOOMIS SAYLES FUNDS II DATE OF NAME CHANGE: 20030718 0000872649 S000006699 Loomis Sayles Growth Fund C000018227 Class A LGRRX C000018229 Class C LGRCX C000018230 Class Y LSGRX C000125484 Class N LGRNX NPORT-P 1 primary_doc.xml NPORT-P false 0000872649 XXXXXXXX S000006699 C000018229 C000018227 C000125484 C000018230 LOOMIS SAYLES FUNDS II 811-06241 0000872649 5493007QOEDY6IHOTU14 888 BOYLSTON STREET Suite 800 BOSTON 02199-8197 617-449-2822 Loomis Sayles Growth Fund S000006699 549300UJ1TECUW4GRJ92 2020-09-30 2020-06-30 N 10596825462.43 6306586.21 10590518876.22 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N Colgate-Palmolive Co YMEGZFW4SBUSS5BQXF88 Colgate-Palmolive Co 194162103 2334720.00000000 NS USD 171041587.20000000 1.615044448710 Long EC CORP US N 1 N N N Alphabet Inc 5493006MHB84DD0ZWV18 Alphabet Inc 02079K107 196505.00000000 NS USD 277781433.05000000 2.622925621460 Long EC CORP US N 1 N N N Varian Medical Systems Inc TK3LAKL7I0QNTCVWSY07 Varian Medical Systems Inc 92220P105 572588.00000000 NS USD 70153481.76000000 0.662417796332 Long EC CORP US N 1 N N N Novartis AG 5493007HIVTX6SY6XD66 Novartis AG 66987V109 2387906.00000000 NS USD 208559710.04000000 1.969305871389 Long EC CORP CH N 1 N N N Regeneron Pharmaceuticals Inc 549300RCBFWIRX3HYQ56 Regeneron Pharmaceuticals Inc 75886F107 705612.00000000 NS USD 440054923.80000000 4.155178126239 Long EC CORP US N 1 N N N Automatic Data Processing Inc HGBOLILQXWER4SAL2I23 Automatic Data Processing Inc 053015103 554718.00000000 NS USD 82591963.02000000 0.779867011100 Long EC CORP US N 1 N N N Amazon.com Inc ZXTILKJKG63JELOEG630 Amazon.com Inc 023135106 296402.00000000 NS USD 817719765.64000000 7.721243644408 Long EC CORP US N 1 N N N Walt Disney Co/The 549300GZKULIZ0WOW665 Walt Disney Co/The 254687106 1763829.00000000 NS USD 196684571.79000000 1.857175971156 Long EC CORP US N 1 N N N Expeditors International of Washington Inc 984500B055A804AB6E40 Expeditors International of Washington Inc 302130109 3233717.00000000 NS USD 245891840.68000000 2.321811079834 Long EC CORP US N 1 N N N salesforce.com Inc RCGZFPDMRW58VJ54VR07 salesforce.com Inc 79466L302 2275834.00000000 NS USD 426331983.22000000 4.025600522532 Long EC CORP US N 1 N N N FactSet Research Systems Inc 549300ZSJE7NBK6K9P30 FactSet Research Systems Inc 303075105 593512.00000000 NS USD 194950886.64000000 1.840805808653 Long EC CORP US N 1 N N N Visa Inc 549300JZ4OKEHW3DPJ59 Visa Inc 92826C839 3405338.00000000 NS USD 657809141.46000000 6.211302289796 Long EC CORP US N 1 N N N Deere & Co PWFTNG3EI0Y73OXWDH08 Deere & Co 244199105 1871861.00000000 NS USD 294162956.15000000 2.777606645983 Long EC CORP US N 1 N N N Oracle Corp 1Z4GXXU7ZHVWFCD8TV52 Oracle Corp 68389X105 7787721.00000000 NS USD 430427339.67000000 4.064270548976 Long EC CORP US N 1 N N N Autodesk Inc FRKKVKAIQEF3FCSTPG55 Autodesk Inc 052769106 2265968.00000000 NS USD 541996885.92000000 5.117755723348 Long EC CORP US N 1 N N N Schlumberger Ltd 213800ZUA17OK3QLGM62 Schlumberger Ltd 000000000 4193444.00000000 NS USD 77117435.16000000 0.728174285522 Long EC CORP CW N 1 N N N Starbucks Corp OQSJ1DU9TAOC51A47K68 Starbucks Corp 855244109 2454103.00000000 NS USD 180597439.77000000 1.705274707318 Long EC CORP US N 1 N N N Yum China Holdings Inc 529900DO9BYZ7VA3K502 Yum China Holdings Inc 98850P109 2267762.00000000 NS USD 109011319.34000000 1.029329352169 Long EC CORP US N 1 N N N Novo Nordisk A/S 549300DAQ1CVT6CXN342 Novo Nordisk A/S 670100205 1655856.00000000 NS USD 108425450.88000000 1.023797343144 Long EC CORP DK N 1 N N N Monster Beverage Corp 52990090AP0E7HCB6F33 Monster Beverage Corp 61174X109 5109600.00000000 NS USD 354197472.00000000 3.344477037808 Long EC CORP US N 1 N N N Boeing Co/The RVHJWBXLJ1RFUBSY1F30 Boeing Co/The 097023105 2003202.00000000 NS USD 367186926.60000000 3.467128767642 Long EC CORP US N 1 N N N Alphabet Inc 5493006MHB84DD0ZWV18 Alphabet Inc 02079K305 196777.00000000 NS USD 279039624.85000000 2.634805981759 Long EC CORP US N 1 N N N FIXED INC CLEARING CORP.REPO 549300H47WTHXPU08X20 FIXED INC CLEARING CORP.REPO 000000000 141633337.37000000 PA USD 141633337.37000000 1.337359755696 Long RA CORP US N 2 Repurchase N 0.00000000 2020-07-01 130262100.00000000 USD 144467741.64000000 USD UST N N N Cisco Systems Inc 8E6NF1YAL0WT6CWXXV93 Cisco Systems Inc 17275R102 4925825.00000000 NS USD 229740478.00000000 2.169303323899 Long EC CORP US N 1 N N N Yum! Brands Inc 549300JE8XHZZ7OHN517 Yum! Brands Inc 988498101 1578113.00000000 NS USD 137153800.83000000 1.295062144102 Long EC CORP US N 1 N N N Facebook Inc BQ4BKCS1HXDV9HN80Z93 Facebook Inc 30303M102 2688707.00000000 NS USD 610524698.49000000 5.764823287939 Long EC CORP US N 1 N N N Roche Holding AG 549300U41AUUVOAAOB37 Roche Holding AG 771195104 8128048.00000000 NS USD 352594722.24000000 3.329343220677 Long EC CORP CH N 1 N N N Intuitive Surgical Inc 54930052SRG011710797 Intuitive Surgical Inc 46120E602 214442.00000000 NS USD 122195484.86000000 1.153819621948 Long EC CORP US N 1 N N N Workday Inc 549300J0DYC0N31V7G13 Workday Inc 98138H101 813061.00000000 NS USD 152335108.96000000 1.438410249209 Long EC CORP US N 1 N N N QUALCOMM Inc H1J8DDZKZP6H7RWC0H53 QUALCOMM Inc 747525103 2429452.00000000 NS USD 221590316.92000000 2.092346177839 Long EC CORP US N 1 N N N SEI Investments Co 5LJTIFADGZ6XH1RVOC11 SEI Investments Co 784117103 3346579.00000000 NS USD 183994913.42000000 1.737355039639 Long EC CORP US N 1 N N N Illumina Inc SQ95QG8SR5Q56LSNF682 Illumina Inc 452327109 478021.00000000 NS USD 177035077.35000000 1.671637427959 Long EC CORP US N 1 N N N Alibaba Group Holding Ltd 5493001NTNQJDH60PM02 Alibaba Group Holding Ltd 01609W102 2581862.00000000 NS USD 556907633.40000000 5.258549084412 Long EC CORP KY N 1 N N N Microsoft Corp INR2EJN1ERAN0W5ZP974 Microsoft Corp 594918104 2477148.00000000 NS USD 504124389.48000000 4.760148160558 Long EC CORP US N 1 N N N NVIDIA Corp 549300S4KLFTLO7GSQ80 NVIDIA Corp 67066G104 1211021.00000000 NS USD 460078988.11000000 4.344253510968 Long EC CORP US N 1 N N N Cerner Corp 549300L4UJ40IEVVI304 Cerner Corp 156782104 2912712.00000000 NS USD 199666407.60000000 1.885331681418 Long EC CORP US N 1 N N N 2020-07-30 LOOMIS SAYLES FUNDS II John Sgroi John Sgroi Assistant Treasurer XXXX NPORT-EX 2 NPORT_14221623319620849.htm HTML

PORTFOLIO OF INVESTMENTS – as of June 30, 2020 (Unaudited)

Loomis Sayles Growth Fund

 

          Shares           

    

Description

             Value (†)            
 

Common Stocks – 98.6% of Net Assets

 
  

Aerospace & Defense – 3.5%

 

  2,003,202     

Boeing Co. (The)

   $ 367,186,927  
     

 

 

 
  

Air Freight & Logistics – 2.3%

 

  3,233,717     

Expeditors International of Washington, Inc.

     245,891,841  
     

 

 

 
  

Beverages – 3.3%

 

  5,109,600     

Monster Beverage Corp.(a)

     354,197,472  
     

 

 

 
  

Biotechnology – 4.2%

 

  705,612     

Regeneron Pharmaceuticals, Inc.(a)

     440,054,924  
     

 

 

 
  

Capital Markets – 3.6%

 

  593,512     

FactSet Research Systems, Inc.

     194,950,887  
  3,346,579     

SEI Investments Co.

     183,994,913  
     

 

 

 
        378,945,800  
     

 

 

 
  

Communications Equipment – 2.2%

 

  4,925,825     

Cisco Systems, Inc.

     229,740,478  
     

 

 

 
  

Energy Equipment & Services – 0.7%

 

  4,193,444     

Schlumberger Ltd.

     77,117,435  
     

 

 

 
  

Entertainment – 1.9%

 

  1,763,829     

Walt Disney Co. (The)

     196,684,572  
     

 

 

 
  

Health Care Equipment & Supplies – 1.8%

 

  214,442     

Intuitive Surgical, Inc.(a)

     122,195,485  
  572,588     

Varian Medical Systems, Inc.(a)

     70,153,482  
     

 

 

 
        192,348,967  
     

 

 

 
  

Health Care Technology – 1.9%

 

  2,912,712     

Cerner Corp.

     199,666,408  
     

 

 

 
  

Hotels, Restaurants & Leisure – 4.0%

 

  2,454,103     

Starbucks Corp.

     180,597,440  
  2,267,762     

Yum China Holdings, Inc.

     109,011,319  
  1,578,113     

Yum! Brands, Inc.

     137,153,801  
     

 

 

 
        426,762,560  
     

 

 

 
  

Household Products – 1.6%

 

  2,334,720     

Colgate-Palmolive Co.

     171,041,587  
     

 

 

 
  

Interactive Media & Services – 11.0%

 

  196,777     

Alphabet, Inc., Class A(a)

     279,039,625  
  196,505     

Alphabet, Inc., Class C(a)

     277,781,433  
  2,688,707     

Facebook, Inc., Class A(a)

     610,524,698  
     

 

 

 
        1,167,345,756  
     

 

 

 
  

Internet & Direct Marketing Retail – 13.0%

 

  2,581,862     

Alibaba Group Holding Ltd., Sponsored ADR(a)

     556,907,633  
  296,402     

Amazon.com, Inc.(a)

     817,719,766  
     

 

 

 
        1,374,627,399  
     

 

 

 


          Shares           

    

Description

             Value (†)            
 

Common Stocks – continued

  
  

IT Services – 7.0%

  
  554,718     

Automatic Data Processing, Inc.

   $ 82,591,963  
  3,405,338     

Visa, Inc., Class A

     657,809,141  
     

 

 

 
        740,401,104  
     

 

 

 
  

Life Sciences Tools & Services – 1.7%

  
  478,021     

Illumina, Inc.(a)

     177,035,077  
     

 

 

 
  

Machinery – 2.8%

  
  1,871,861     

Deere & Co.

     294,162,956  
     

 

 

 
  

Pharmaceuticals – 6.3%

  
  2,387,906     

Novartis AG, Sponsored ADR

     208,559,710  
  1,655,856     

Novo Nordisk A/S, Sponsored ADR

     108,425,451  
  8,128,048     

Roche Holding AG, Sponsored ADR

     352,594,722  
     

 

 

 
        669,579,883  
     

 

 

 
  

Semiconductors & Semiconductor Equipment – 6.4%

  
  1,211,021     

NVIDIA Corp.

     460,078,988  
  2,429,452     

QUALCOMM, Inc.

     221,590,317  
     

 

 

 
        681,669,305  
     

 

 

 
  

Software – 19.4%

  
  2,265,968     

Autodesk, Inc.(a)

     541,996,886  
  2,477,148     

Microsoft Corp.

     504,124,389  
  7,787,721     

Oracle Corp.

     430,427,340  
  2,275,834     

salesforce.com, Inc.(a)

     426,331,983  
  813,061     

Workday, Inc., Class A(a)

     152,335,109  
     

 

 

 
        2,055,215,707  
     

 

 

 
  

Total Common Stocks
(Identified Cost $6,495,194,826)

     10,439,676,158  
     

 

 

 
Principal
Amount
                
 

Short-Term Investments – 1.3%

  
  $   141,633,338     

Tri-Party Repurchase Agreement with Fixed Income Clearing Corporation, dated 6/30/2020 at 0.000% to be repurchased at $141,633,338 on 7/01/2020 collateralized by $44,967,600 U.S. Treasury Note, 2.375% due 4/30/2026 valued at $50,336,993; $85,294,500 U.S. Treasury Note, 2.125% due 5/31/2026 valued at $94,129,117 including accrued interest(b)
(Identified Cost $141,633,338)

     141,633,338  
     

 

 

 
  

Total Investments – 99.9%
(Identified Cost $6,636,828,164)

     10,581,309,496  
  

Other assets less liabilities – 0.1%

     13,020,399  
     

 

 

 
  

Net Assets – 100.0%

   $ 10,594,329,895  
     

 

 

 


(†)

Fund securities and other investments are valued at market value based on market quotations obtained or determined by independent pricing services recommended by the adviser and approved by the Board of Trustees. Fund securities and other investments for which market quotations are not readily available are valued at fair value as determined in good faith by the adviser pursuant to procedures approved by the Board of Trustees, as described below. Market value is determined as follows:

Listed equity securities (including shares of closed-end investment companies and exchange-traded funds) are valued at the last sale price quoted on the exchange where they are traded most extensively or, if there is no reported sale during the day, the closing bid quotation as reported by an independent pricing service. Securities traded on the NASDAQ Global Select Market, NASDAQ Global Market and NASDAQ Capital Market are valued at the NASDAQ Official Closing Price (“NOCP”), or if lacking an NOCP, at the most recent bid quotations on the applicable NASDAQ Market. Unlisted equity securities (except unlisted preferred equity securities) are valued at the last sale price quoted in the market where they are traded most extensively or, if there is no reported sale during the day, the closing bid quotation as reported by an independent pricing service. If there is no last sale price or closing bid quotation available, unlisted equity securities will be valued using evaluated bids furnished by an independent pricing service, if available.

In some foreign markets, an official close price and a last sale price may be available from the foreign exchange or market. In those cases, the official close price is used.

Debt securities and unlisted preferred equity securities are valued based on evaluated bids furnished to the Fund by an independent pricing service or bid prices obtained from broker-dealers.

Broker-dealer bid prices may be used to value debt and unlisted equity securities where an independent pricing service is unable to price a security or where an independent pricing service does not provide a reliable price for the security.

Fund securities and other investments for which market quotations are not readily available are valued at fair value as determined in good faith by the adviser pursuant to procedures approved by the Board of Trustees. The Fund may also value securities and other investments at fair value in other circumstances such as when extraordinary events occur after the close of a foreign market but prior to the close of the New York Stock Exchange. This may include situations relating to a single issuer (such as a declaration of bankruptcy or a delisting of the issuer’s security from the primary market on which it has traded) as well as events affecting the securities markets in general (such as market disruptions or closings and significant fluctuations in U.S. and/or foreign markets). When fair valuing its securities or other investments, the Fund may, among other things, use modeling tools or other processes that may take into account factors such as securities or other market activity and/or significant events that occur after the close of the foreign market and before the time the Fund’s net asset value (“NAV”) is calculated. Fair value pricing may require subjective determinations about the value of a security, and fair values used to determine the Fund’s NAV may differ from quoted or published prices, or from prices that are used by others, for the same securities. In addition, the use of fair value pricing may not always result in adjustments to the prices of securities held by the Fund.

The books and records of the Fund are maintained in U.S. dollars. The values of securities, currencies and other assets and liabilities denominated in currencies other than U.S. dollars are translated into U.S. dollars based upon foreign exchange rates prevailing at the end of the period.

 

(a)

Non-income producing security.

(b)

The Fund may enter into repurchase agreements, under the terms of a Master Repurchase Agreement, under which the Fund acquires securities as collateral and agrees to resell the securities at an agreed upon time and at an agreed upon price. It is the Fund’s policy that the market value of the collateral for repurchase agreements be at least equal to 102% of the repurchase price, including interest. Certain repurchase agreements are tri-party arrangements whereby the collateral is held in a segregated account for the benefit of the Fund and on behalf of the counterparty. Repurchase agreements could involve certain risks in the event of default or insolvency of the counterparty, including possible delays or restrictions upon the Fund’s ability to dispose of the underlying securities. As of June 30, 2020, the Fund had an investment in a repurchase agreement for which the value of the related collateral exceeded the value of the repurchase agreement.

 

ADR

An American Depositary Receipt is a certificate issued by a custodian bank representing the right to receive securities of the foreign issuer described. The values of ADRs may be significantly influenced by trading on exchanges not located in the United States.


Fair Value Measurements

In accordance with accounting standards related to fair value measurements and disclosures, the Fund has categorized the inputs utilized in determining the value of the Fund’s assets or liabilities. These inputs are summarized in the three broad levels listed below:

 

   

Level 1 — quoted prices in active markets for identical assets or liabilities;

 

   

Level 2 — prices determined using other significant inputs that are observable either directly, or indirectly through corroboration with observable market data (which could include quoted prices for similar assets or liabilities, interest rates, credit risk, etc.); and

 

   

Level 3 — prices determined using significant unobservable inputs when quoted prices or observable inputs are unavailable such as when there is little or no market activity for an asset or liability (unobservable inputs reflect the Fund’s own assumptions in determining the fair value of assets or liabilities and would be based on the best information available).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.


The following is a summary of the inputs used to value the Fund’s investments as of June 30, 2020, at value:

Asset Valuation Inputs

 

Description

   Level 1      Level 2      Level 3      Total  

Common Stocks*

   $ 10,439,676,158      $      $ —        $ 10,439,676,158  

Short-Term Investments

     —          141,633,338        —          141,633,338  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 10,439,676,158      $ 141,633,338      $ —        $ 10,581,309,496  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

*

Details of the major categories of the Fund’s investments are reflected within the Portfolio of Investments.


Industry Summary at June 30, 2020 (Unaudited)

 

Software

     19.4

Internet & Direct Marketing Retail

     13.0  

Interactive Media & Services

     11.0  

IT Services

     7.0  

Semiconductors & Semiconductor Equipment

     6.4  

Pharmaceuticals

     6.3  

Biotechnology

     4.2  

Hotels, Restaurants & Leisure

     4.0  

Capital Markets

     3.6  

Aerospace & Defense

     3.5  

Beverages

     3.3  

Machinery

     2.8  

Air Freight & Logistics

     2.3  

Communications Equipment

     2.2  

Other Investments, less than 2% each

     9.6  

Short-Term Investments

     1.3  
  

 

 

 

Total Investments

     99.9  

Other assets less liabilities

     0.1  
  

 

 

 

Net Assets

     100.0